Clinical Trials on Paroxysmal Sympathetic Hyperactivity in Singapore
Total 15 results
-
National Healthcare Group, SingaporeDuke-NUS Graduate Medical School; Institute for Infocomm ResearchCompletedAttention Deficit Hyperactivity DisorderSingapore
-
National Healthcare Group, SingaporeDuke-NUS Graduate Medical School; Agency for Science, Technology and Research; Singapore Clinical Research InstituteCompletedAttention Deficit Hyperactivity DisorderSingapore
-
National Healthcare Group, SingaporeUniversity of Pennsylvania; Nanyang Technological University; Alexandra Hospital and other collaboratorsCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant DisorderSingapore
-
Duke-NUS Graduate Medical SchoolInstitute of Mental Health, Singapore; Agency for Science, Technology and ResearchCompletedAttention Deficit Hyperactivity Disorder | Autism Spectrum DisordersSingapore
-
Institute of Mental Health, SingaporeCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity DisorderSingapore
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaTaiwan, Singapore, Korea, Republic of, Malaysia
-
Novartis PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)China, Germany, Singapore, Korea, Republic of, Italy, United Kingdom, Malaysia, France
-
Novartis PharmaceuticalsCompletedAttention Deficit/Hyperactivity DisorderUnited States, Germany, Singapore, Colombia, Sweden, Belgium, South Africa, Denmark, Norway
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, Malaysia, Singapore, Serbia, Peru, Philippines, Colombia, Mexico, Poland
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaTaiwan, Korea, Republic of, Turkey, Spain, Thailand, Singapore, Japan, Canada, Malaysia, Poland, Italy
-
AlexionCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Belgium, France, Italy, Japan, Spain, Taiwan, United Kingdom, United States, Canada, Czechia, Germany, Sweden, Singapore, Korea, Republic of, Russian Federation, Austria, Poland, Argentina, Australia, Brazil, Estonia, Malaysia, Mexico, Thaila... and more
-
Regeneron PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaMexico, Korea, Republic of, Turkey, Italy, United Kingdom, Thailand, Poland, Singapore, Spain, Taiwan, Canada, Japan, United States, Malaysia, Greece, Romania, Hungary
-
Hoffmann-La RocheChugai PharmaceuticalActive, not recruitingParoxysmal Nocturnal HemoglobinuriaSpain, Korea, Republic of, France, Sweden, Thailand, Malaysia, China, Turkey, Netherlands, Japan, Australia, United Kingdom, Germany, Brazil, Romania, Argentina, Poland, Greece, Hong Kong, Lithuania, Mexico, Philippines, Portugal, Sin... and more
-
Novartis PharmaceuticalsRecruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Korea, Republic of, Singapore, Germany, Taiwan, Italy, Turkey, France, Malaysia, Lithuania, Netherlands, United Kingdom, Japan, Czechia, Spain, China, Brazil
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Korea, Republic of, Spain, Germany, Estonia, Japan, Colombia, Saudi Arabia, Turkey, Brazil, France, Greece, Poland, Taiwan, Netherlands, Italy, Australia, Sweden, Singapore, Portugal, Hungary, Belgium, Canada, Czechia, Hong... and more